Oxaliplatin 50mg Injection

Oxaliplatin 50mg Injection is a highly potent, third-generation platinum-based antineoplastic agent widely utilized in the systemic treatment of advanced gastrointestinal malignancies. As a cytotoxic coordination complex, Oxaliplatin 50mg Injection functions as an alkylating agent that targets the genetic blueprint of rapidly dividing cells. Upon administration, the active platinum compounds form both inter-strand and intra-strand cross-links with DNA, specifically targeting the guanine and cytosine bases. These rigid cross-links act as physical barriers that effectively inhibit DNA replication and transcription. When the cancer cell attempts to divide, the presence of these lesions triggers a cascade of signaling pathways that lead to cell cycle arrest and, ultimately, apoptosis (programmed cell death). Discover how this professional pharmaceutical intervention provides the ultimate clinical strategy for combating colorectal cancer, offering patients effective relief and improved survival rates through its unique ability to synergize with other chemotherapeutic agents like fluorouracil.

The distinctive pharmacological profile of Oxaliplatin 50mg Injection sets it apart from older platinum derivatives like cisplatin and carboplatin. It features a 1,2-diaminocyclohexane (DACH) carrier ligand, which helps the drug overcome cellular resistance mechanisms that often neutralize other platinum therapies. This structural innovation allows Oxaliplatin 50mg Injection to remain effective even in tumors that have become refractory to first-line treatments. The 50mg vial strength is specifically designed to facilitate precise, body surface area-based dosing, ensuring that oncologists can tailor the regimen to the individual patient’s tolerance and metabolic capacity.

Indications / Uses of Oxaliplatin 50mg Injection

Oxaliplatin 50mg Injection is commonly prescribed for the specialized management of the following oncological conditions:

• Adjuvant Treatment of Stage III Colon Cancer: It is indicated for patients who have undergone complete resection of the primary tumor. When used in combination with infusional 5-fluorouracil and leucovorin (the FOLFOX regimen), Oxaliplatin 50mg Injection significantly reduces the risk of disease recurrence.
• Advanced Colorectal Cancer: The medication is a first-line therapy for the treatment of metastatic colorectal cancer. It provides a powerful systemic attack to shrink tumors and control the spread of the disease to the liver or lungs.
• Recurrent Ovarian Cancer: In certain clinical settings, Oxaliplatin 50mg Injection acts as an effective relief option for patients with ovarian cancer that has progressed after platinum-taxane therapy.
• Pancreatic and Gastric Cancers (Off-Label): Oncologists may utilize this agent as part of combination protocols to treat advanced pancreatic or gastric adenocarcinomas, leveraging its broad-spectrum cytotoxic activity.

Key Features

• Unique DACH Ligand Structure: The primary feature of Oxaliplatin 50mg Injection is its chemical architecture, which prevents the cell’s mismatch repair enzymes from fixing the DNA damage, thereby increasing lethality to cancer cells.
• Synergistic Potency: It acts as a biochemical modulator that enhances the cytotoxic effects of fluoropyrimidines (like 5-FU), creating a “1+1=3” therapeutic effect that is superior to using either drug alone.
• Reduced Renal Toxicity: Unlike cisplatin, Oxaliplatin 50mg Injection typically does not cause severe kidney damage, reducing the need for aggressive hydration protocols during infusion.
• IV Infusion Delivery: The injection is administered intravenously, ensuring 100% bioavailability and immediate systemic distribution to target metastatic sites.
• Established Efficacy: Clinical trials have consistently shown that regimens containing Oxaliplatin 50mg Injection improve progression-free survival and overall survival in colorectal cancer populations.

Storage for Oxaliplatin 50mg Injection

To preserve the chemical stability and ultimate potency of the platinum complex, Oxaliplatin 50mg Injection should be stored in its original packaging to protect it from light. If the product is a lyophilized powder, it can typically be stored at controlled room temperature, between 20°C and 25°C (68°F to 77°F). However, if supplied as a concentrated solution, many manufacturers recommend refrigeration between 2°C and 8°C (36°F to 46°F); always check the specific package insert. Do not freeze the solution, as this can cause precipitation. Once diluted for infusion, the solution should be used within specific timeframes (usually 6 to 24 hours) to ensuring microbiological safety. Keep the medication in a secure, professional medical storage area that is strictly out of the reach of children.

Important Note on Oxaliplatin 50mg Injection

The administration of Oxaliplatin 50mg Injection requires strict adherence to compatibility guidelines. Crucially, Oxaliplatin 50mg Injection must never be mixed with or administered through the same line as saline (sodium chloride) solutions. Chloride ions cause the drug to degrade rapidly; it must only be diluted in 5% Dextrose in Water (D5W).

A unique and significant side effect of this medication is acute cold sensitivity (cold-induced dysesthesia). Patients may experience painful tingling or numbness in the hands, feet, or throat triggered by exposure to cold. During treatment and for several days after, patients must avoid cold drinks, ice, and exposure to cold air (covering the mouth and nose with a scarf is recommended). This acute neurotoxicity can also cause a sensation of difficulty breathing or swallowing.

Chronic peripheral sensory neuropathy is another risk, which correlates with the cumulative dose. Patients should report any persistent numbness or difficulty with fine motor tasks (like buttoning a shirt). Oxaliplatin 50mg Injection also causes myelosuppression (neutropenia, thrombocytopenia); frequent blood tests are mandatory to monitor for infection risks. Anaphylactic reactions can occur within minutes of administration, so observation is required. By strictly following these professional guidelines and avoiding cold triggers, patients can safely maximize the powerful anti-tumor benefits of Oxaliplatin 50mg Injection.